These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Updates in the Management of Advanced Nonmelanoma Skin Cancer. Yan F; Schmalbach CE Surg Oncol Clin N Am; 2024 Oct; 33(4):723-733. PubMed ID: 39244290 [TBL] [Abstract][Full Text] [Related]
4. Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers. Komatsubara KM; Jeter J; Carvajal RD; Margolin K; Schadendorf D; Hauschild A Am Soc Clin Oncol Educ Book; 2017; 37():641-650. PubMed ID: 28561682 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma. Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490 [TBL] [Abstract][Full Text] [Related]
6. Systemic therapy of skin carcinoma. Kempf RA Cancer Treat Res; 1995; 78():137-62. PubMed ID: 8595141 [No Abstract] [Full Text] [Related]
8. Non-Melanoma Skin Cancers: Biological and Clinical Features. Cives M; Mannavola F; Lospalluti L; Sergi MC; Cazzato G; Filoni E; Cavallo F; Giudice G; Stucci LS; Porta C; Tucci M Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751327 [TBL] [Abstract][Full Text] [Related]
9. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial. Dessinioti C; Plaka M; Stratigos AJ Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979 [TBL] [Abstract][Full Text] [Related]
11. Vismodegib: a guide to its use in locally advanced or metastatic basal cell carcinoma. Lyseng-Williamson KA; Keating GM Am J Clin Dermatol; 2013 Feb; 14(1):61-4. PubMed ID: 23329081 [TBL] [Abstract][Full Text] [Related]
12. New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma. Villani A; Potestio L; Fabbrocini G; Scalvenzi M Adv Ther; 2022 Mar; 39(3):1164-1178. PubMed ID: 35089534 [TBL] [Abstract][Full Text] [Related]
13. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma. Cirrone F; Harris CS Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338 [TBL] [Abstract][Full Text] [Related]
14. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib. Chang AL; Solomon JA; Hainsworth JD; Goldberg L; McKenna E; Day BM; Chen DM; Weiss GJ J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279 [TBL] [Abstract][Full Text] [Related]
15. U.S. Food and Drug Administration approval: vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma. Axelson M; Liu K; Jiang X; He K; Wang J; Zhao H; Kufrin D; Palmby T; Dong Z; Russell AM; Miksinski S; Keegan P; Pazdur R Clin Cancer Res; 2013 May; 19(9):2289-93. PubMed ID: 23515405 [TBL] [Abstract][Full Text] [Related]
16. Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus. Peris K; Licitra L; Ascierto PA; Corvò R; Simonacci M; Picciotto F; Gualdi G; Pellacani G; Santoro A Future Oncol; 2015; 11(4):703-12. PubMed ID: 25686123 [TBL] [Abstract][Full Text] [Related]
17. Medical management of cutaneous malignancies. Gibbs P; Gonzalez R; Lee LA; Walsh P Clin Dermatol; 2001; 19(3):298-304. PubMed ID: 11479042 [No Abstract] [Full Text] [Related]
19. Vismodegib: A Review in Advanced Basal Cell Carcinoma. Frampton JE; Basset-Séguin N Drugs; 2018 Jul; 78(11):1145-1156. PubMed ID: 30030732 [TBL] [Abstract][Full Text] [Related]
20. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma. Ascierto PA; Schadendorf D J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]